Skip to main content
Contact Us
Subscribe
E-Edition
76°
Site search
Search
Menu
Open user controls
Log In Using Your Account
Log In
Don't have an account?
Sign Up Today
My Account
Dashboard
Profile
Saved items
Logout
Home
About Us
Contact Us
Advertise
Terms and Conditions
Privacy Policy
Home Delivery
Subscription Services
Place an Ad
Promote Your Event
Local Weather
News
Sports
Obits
Multimedia
Photo Galleries
Videos
e-Edition
Classifieds
Real Estate
Property For Rent
Cars & Vehicles
Jobs
Items For Sale
Pets
Auctions, Estate & Garage Sales
Services
Community
Personals
Place An Ad
Subscribe
Best of 2024
Archives
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Articles published by Corcept Therapeutics Incorporated
Corcept Therapeutics to Announce First Quarter Financial Results, Provide Corporate Update and Host Conference Call
Today 16:05 EDT
From
Corcept Therapeutics Incorporated
Via
GlobeNewswire
Tickers
CORT
Corcept Announces Positive Results From Open-Label Portion of Pivotal Phase 3 GRACE Trial in Patients With Cushing’s Syndrome
April 22, 2024
From
Corcept Therapeutics Incorporated
Via
GlobeNewswire
Tickers
CORT
Corcept Completes Enrollment in Phase 2 DAZALS Trial in Patients With Amyotrophic Lateral Sclerosis (ALS)
April 15, 2024
From
Corcept Therapeutics Incorporated
Via
GlobeNewswire
Tickers
CORT
Corcept Completes Enrollment in Pivotal Phase 3 Rosella Trial of Relacorilant in Patients With Platinum-Resistant Ovarian Cancer
April 08, 2024
From
Corcept Therapeutics Incorporated
Via
GlobeNewswire
Tickers
CORT
Corcept Completes Enrollment in Phase 3 Gradient Trial of Relacorilant in Patients With Adrenal Cushing’s Syndrome
April 01, 2024
From
Corcept Therapeutics Incorporated
Via
GlobeNewswire
Tickers
CORT
Corcept Therapeutics Announces Fourth Quarter and Full-Year 2023 Audited Financial Results and Provides Corporate Update
February 15, 2024
From
Corcept Therapeutics Incorporated
Via
GlobeNewswire
Tickers
CORT
Corcept Announces Preliminary Results From Prevalence Phase Of CATALYST Clinical Trial
February 15, 2024
From
Corcept Therapeutics Incorporated
Via
GlobeNewswire
Tickers
CORT
Corcept Therapeutics to Announce Fourth Quarter and Full-Year 2023 Financial Results, Provide Corporate Update and Host Conference Call
February 08, 2024
From
Corcept Therapeutics Incorporated
Via
GlobeNewswire
Tickers
CORT
Corcept Appoints Roberto Vieira as President, Oncology
January 29, 2024
From
Corcept Therapeutics Incorporated
Via
GlobeNewswire
Tickers
CORT
Corcept Therapeutics Provides Financial Update and Announces Stock Repurchase Program
January 08, 2024
From
Corcept Therapeutics Incorporated
Via
GlobeNewswire
Tickers
CORT
Court Finds Corcept Therapeutics’ Patents Not Infringed
January 02, 2024
From
Corcept Therapeutics Incorporated
Via
GlobeNewswire
Tickers
CORT
Corcept Therapeutics Announces Third Quarter Financial Results and Provides Corporate Update
November 01, 2023
From
Corcept Therapeutics Incorporated
Via
GlobeNewswire
Tickers
CORT
Corcept Appoints Monica Tellado as President, Emerging Markets
November 01, 2023
From
Corcept Therapeutics Incorporated
Via
GlobeNewswire
Tickers
CORT
Corcept Initiates MONARCH – A Phase 2b Trial in Non-Alcoholic Steatohepatitis (NASH)
October 26, 2023
From
Corcept Therapeutics Incorporated
Via
GlobeNewswire
Tickers
CORT
Corcept Therapeutics to Announce Third Quarter Financial Results, Provide Corporate Update and Host Conference Call
October 25, 2023
From
Corcept Therapeutics Incorporated
Via
GlobeNewswire
Tickers
CORT
Corcept Therapeutics Announces Second Quarter Financial Results and Provides Corporate Update
August 02, 2023
From
Corcept Therapeutics Incorporated
Via
GlobeNewswire
Tickers
CORT
Corcept Therapeutics to Announce Second Quarter Financial Results, Provide Corporate Update and Host Conference Call
July 26, 2023
From
Corcept Therapeutics Incorporated
Via
GlobeNewswire
Tickers
CORT
Corcept’s Miricorilant Shows Great Promise in Treatment of Non-Alcoholic Steatohepatitis (NASH)
July 17, 2023
From
Corcept Therapeutics Incorporated
Via
GlobeNewswire
Tickers
CORT
Journal of Clinical Oncology Publishes Results of Corcept’s Phase 2 Trial of Relacorilant in Women With Platinum-Resistant Ovarian Cancer
June 27, 2023
From
Corcept Therapeutics Incorporated
Via
GlobeNewswire
Tickers
CORT
Corcept Therapeutics Announces First Quarter Financial Results and Provides Corporate Update
May 03, 2023
From
Corcept Therapeutics Incorporated
Via
GlobeNewswire
Tickers
CORT
Corcept Therapeutics to Announce First Quarter Financial Results, Provide Corporate Update and Host Conference Call
April 26, 2023
From
Corcept Therapeutics Incorporated
Via
GlobeNewswire
Tickers
CORT
Corcept Therapeutics Announces Final Results of Tender Offer
April 05, 2023
From
Corcept Therapeutics Incorporated
Via
GlobeNewswire
Tickers
CORT
Corcept Therapeutics Announces Preliminary Results of Tender Offer
April 03, 2023
From
Corcept Therapeutics Incorporated
Via
GlobeNewswire
Tickers
CORT
Corcept Therapeutics Initiates CATALYST Clinical Trial
March 28, 2023
From
Corcept Therapeutics Incorporated
Via
GlobeNewswire
Tickers
CORT
Corcept Therapeutics Announces Commencement of Tender Offer to Purchase up to 7,500,000 Shares of its Common Stock
March 06, 2023
From
Corcept Therapeutics Incorporated
Via
GlobeNewswire
Tickers
CORT
Corcept Therapeutics Announces Fourth Quarter and Full-Year 2022 Audited Financial Results and Provides Corporate Update
February 28, 2023
From
Corcept Therapeutics Incorporated
Via
GlobeNewswire
Tickers
CORT
Corcept Therapeutics to Announce Fourth Quarter and Full-Year 2022 Financial Results, Provide Corporate Update and Host Conference Call
February 14, 2023
From
Corcept Therapeutics Incorporated
Via
GlobeNewswire
Tickers
CORT
Corcept Therapeutics Announces Preliminary Settlement of Purported Securities Class Action Litigation
February 13, 2023
From
Corcept Therapeutics Incorporated
Via
GlobeNewswire
Tickers
CORT
Corcept Therapeutics Settles Patent Litigation with Hikma Pharmaceuticals
December 08, 2022
From
Corcept Therapeutics Incorporated
Via
GlobeNewswire
Tickers
CORT
Corcept Therapeutics Provides Miricorilant Clinical Development Update
December 08, 2022
From
Corcept Therapeutics Incorporated
Via
GlobeNewswire
Tickers
CORT
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.